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Abstract
Neonatal monocytes display immaturity of numerous functions compared with adult cells. Gene
expression arrays provide a promising tool for elucidating mechanisms underlying neonatal immune
function. We used a well-established microarray to analyze differences between LPS-stimulated
human cord blood and adult monocytes to create dynamic models for interactions to elucidate
observed deficiencies in neonatal immune responses.
We identified 168 genes that were differentially expressed between adult and cord monocytes after
45 min incubation with LPS. Of these genes, 95% (159 of 167) were over-expressed in adult relative
to cord monocytes. Differentially expressed genes could be sorted into nine groups according to
their kinetics of activation. Functional modelling suggested differences between adult and cord
blood in the regulation of apoptosis, a finding confirmed using annexin binding assays. We conclude
that kinetic studies of gene expression reveal potentially important differences in gene expression
dynamics that may provide insight into neonatal innate immunity.
Background
The defects in neonatal adaptive immunity are relatively
easy to understand a priori. Although there are complexi-
ties to be considered [1,2], experimental evidence demon-
strates that newborns, lacking prior antigen exposure,
must develop immunologic memory based on postnatal
experience with phogens and environmental immuno-
gens [3-5].
It is less clear why there should be defects in newborns'
innate immunity, although these defects are well docu-
mented. For example, newborns have long been known to
exhibit defects in phagocytosis [6], chemotaxis [7,8], and
adherence [9], the latter possibly due to aberrant regula-
tion of critical cell-surface proteins that mediate leuko-
cyte-endothelial interactions [10]. Newborn monocytes
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also exhibit diminished secretion of numerous cytokines
under both stimulated and basal conditions [11-13].
Elucidating the causes of these defects is a crucial question
in neonatal medicine, since infection remains a major
cause of morbidity and mortality in the newborn period.
However, unravelling the complex events in monocyte
and/or neutrophil activation, from ligand binding to acti-
vation of effector responses, is clearly a daunting chal-
lenge. Any one of numerous pathways from the earliest
cell signalling events to protein synthesis or secretion
could be relevant, and focusing on any one may overlook
critical aspects of cellular regulation. In this context,
genomic and/or proteomic approaches may offer some
important advantages, at least in the initial phases of
investigation, by allowing investigators to survey the pan-
oply of biological processes that may be relevant to iden-
tifying critical biological distinctions.
Recently published work has documented differences in
gene expression between adult and cord blood monocytes
[14], although these studies did not elucidate the funda-
mental, functional differences between cord blood and
adult cells. The studies we report here demonstrate how
computational analyses, applied to microarray data, can
elucidate critical biological functions when analysis
extends beyond the identification of differentially-
expressed genes.
Methods
Cells and cellular stimulation
Monocytes were purified from cord blood of healthy,
term infants and from the peripheral blood of healthy
adults by positive selection using anti-CD-14 mAb-coated
magnetic beads (Miltenyi Biotec, Auburn, CA, USA)
according to the manufacturer's instructions. Informed
consent was obtained from adult volunteers; collection of
cord blood was ruled exempt from consent after review by
the Oklahoma Health Sciences Center IRB. In brief, blood
was collected into sterile tubes containing sodium citrate
as an anticoagulant (Becton Dickinson, Franklin Lakes,
NJ). Peripheral blood mononuclear cells (PBMC) were
prepared from the anti-coagulated blood using gradient
separation on Histopaque-1077 performed directly in the
blood collection tubes. Cells were washed three times in
Ca2+ and Mg2+-free Hanks's balanced salt solution. PBMC
were incubated for 20 min at 4°C with CD14 microbeads
at 20 μl/1 × 107 cells. The cells were washed once, re-sus-
pended in 500 μl Ca2+ and Mg2+-free PBS containing 5%
FBS/1 × 108 cells. The suspension was then applied to a
MACs column. After unlabeled cells passed through, the
column was washed with 3 × 500 μl Ca2+ and Mg2+-free
PBS. The column was removed from the separator and
was put on a new collection tube. One ml of Ca2+ and
Mg2+-free PBS was then added onto the column, which
was immediately flushed by firmly applying the plunger
supplied with the column.
Purified monocytes were incubated with LPS from
Escherichia coli 0111:4B (Sigma, St. Louis, MO) at 10 ng/
ml for 45 min and 2-hours in RPMI 1640 with 10% fetal
bovine serum or studied in the absence of stimulation
("zero time"). It should be noted that this product is not
"pure," and stimulates both TLR-4 and TRL-2 signaling
pathways [15]. A smaller number of replicates (n = 5) was
analyzed after 24 hr incubation. After the relevant time
points, monocytes were lysed with TriZol (Invitrogen,
Carlsbad, CA, USA) and RNA was isolated as recom-
mended by the manufacturer. Cells from eight different
term neonates and eight different healthy adults were
used for these studies.
Gene microarrays
The microarrays used in these experiments were devel-
oped at the Oklahoma Medical Research Foundation
Microarray Research Facility and contained probes for
21,329 human genes. Slides were produced using com-
mercially available libraries of 70 nucleotide long DNA
molecules whose length and sequence specificity were
optimized to reduce the cross-hybridization problems
encountered with cDNA-based microarrays (Qiagen-
Operon). The oligonucleotides were derived from the
UniGene and RefSeq databases. The RefSeq database is an
effort by the NCBI to create a true reference database of
genomic information for all genes of known function. All
11,000 human genes of known or suspected function
were represented on these arrays. In addition, most unde-
fined open reading frames were represented (approxi-
mately 10,000 additional genes).
Oligonucleotides were spotted onto Corning®  Ultra-
GAPS™ amino-silane coated slides, rehydrated with water
vapor, snap dried at 90°C, and then covalently fixed to
the surface of the glass using 300 mJ, 254 nm wavelength
ultraviolet radiation. Unbound free amines on the glass
surface were blocked for 15 min with moderate agitation
in a 143 mM solution of succinic anhydride dissolved in
1-methyl-2-pyrolidinone, 20 mM sodium borate, pH 8.0.
Slides were rinsed for 2 min in distilled water, immersed
for 1 min in 95% ethanol, and dried with a stream of
nitrogen gas.
Labeling, hybridization, and scanning
Fluorescently labeled cDNA was separately synthesized
from 2.0 μg of total RNA using an oligo dT12–18 primer,
PowerScript reverse transcriptase (Clontech, Palo Alto,
CA), and Cy3-dUTP (Amersham Biosciences, Piscataway,
NJ) for 1 hour at 42°C in a volume of 40 μl. Reactions
were quenched with 0.5 M EDTA and the RNA was hydro-
lyzed by addition of 1 M NaOH for 1 hr at 65°C. The reac-Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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tion was neutralized with 1 M Tris, pH 8.0, and cDNA was
then purified with the Montage PCR96 Cleanup Kit (Milli-
pore, Billerica, MA). cDNA was added to ChipHybe™
hybridization buffer (Ventana Medical Systems, Tucson,
AZ) containing Cot-1 DNA (0.5 mg/ml final concentra-
tion), yeast tRNA (0.2 mg/ml), and poly(dA)40–60 (0.4
mg/ml). Hybridization was performed on a Ventana Dis-
covery system for 6 hr at 42°C. Microarrays were washed
to a final stringency of 0.1× SSC, and then scanned using
a dual-color laser (Agilent Biotechnologies, Palo Alto,
CA). Fluorescent intensity was measured by Imagene™
software (BioDiscovery, El Segundo, CA).
PCR validation of array data
Reverse transcription
Three cord blood samples (C1, C2, and C5) and three
adult samples (A1, A5, and A6) from the 45 minute time
point were used for PCR validation. First strand cDNA was
generated from 3.6 μg of total RNA per sample using the
OmniScript Reverse Transcriptase and buffer (Qiagen,
Valencia, CA), 1 μl of 100 μM oligo dT primer (dT15) in a
40 μl volume. Reactions were incubated 60 min at 37°
and inactivated at 93° for 5 min. cDNA was diluted 1:100
in water and stored at -20°C.
Quantitative PCR
Gene-specific primers for 10 genes (Erbb3, Tmod, Dscr1l1,
Sp1, Scya4, Gro2, Cri1, Scya3, Scya3l1, and Il-1a) were
designed with a 60°C melting temperature and a length of
19–25 bp for PCR products with a length of 90–140 bp,
using Applied Biosystems Inc (ABI, Foster City, CA)
Primer Express 1.5 software. PCR was run with 2 μl cDNA
template in 15 μl reactions in triplicate on an ABI SDS
7700 using the ABI SYBR Green I Master Mix and gene
specific primers at a concentration of 1 μM each. The tem-
perature profile consisted of an initial 95°C step for 10
minutes (for Taq activation), followed by 40 cycles of
95°C for 15 sec, 60°C for 1 min, and then a final melting
curve analysis with a ramp from 60°C to 95°C over 20
min. Gene-specific amplification was confirmed by a sin-
gle peak in the ABI Dissociation Curve software. No tem-
plate controls were run for each primer pair. Since equal
amounts of total RNA were used for cDNA synthesis, Ct
values should reflect relative abundance [16]. These val-
ues were used to calculate the average group Ct (Cord vs.
Adult) and the relative ΔCt was used to calculate fold
change between the two groups [17].
Apoptosis assays
Exposed membrane phospholipids (a marker for early
apoptosis) were detected in adult and neonatal mono-
cytes after LPS stimulation using a commercially available
annexin V binding assay. Monocytes from cord blood and
adult peripheral blood were obtained as outlined above.
Isolated monocytes were either labeled immediately with
annexin V-FITC or were stimulated for 14 hours with LPS
10 ng/ml prior to labeling (this time point was derived
empirically to maximize apoptosis). Annexin V-FITC
staining was completed via the Annexin V-FITC Apoptosis
Detection Kit I (BD Biosciences, San Jose, CA) using 5 μl
of propidium iodine and 5 μl annexin V-FITC as recom-
mended by the manufacturer. Analysis by flow cytometry
was accomplished on a FACS Calibur automated bench-
top flow cytometer. Data obtained by flow cytometry was
analyzed by non-parametric t-test (Mann-Whitney test).
An alpha level of 0.05 was considered statistically signifi-
cant.
Statistical analysis
Microarrays were normalized and tested for differential
expression using methods described previously [18]. Dif-
ferential expression was concluded if the genes met the
following criteria: a minimum expression level at least 10
times above background at one or more time points, a
minimum 1.5-fold difference in the mean expression val-
ues between groups at one or more time points, and a
minimum of 80% reproducibility using the jack-knife
method. A jack-knife is the most common type of Leave-
one-out-cross-validation (LOOCV); it is used here to
cross-validate genes selected by differential analysis [19].
Time series analysis was performed using the hypervaria-
ble (HV) gene method previously described by our group
[20].
After selection, HV genes are clustered and interrogated
for gene-gene interactions. K-means clustering, an unsu-
pervised technique, was performed on the HV genes to
create unbiased clusters. Discriminate function analysis
(DFA), a supervised technique, was used to determine and
spatially map gene-to-gene interactions [21].
All statistical analysis was performed in Matlab R14 (Nat-
ick, MA) and Statistica v7 (Tulsa, OK, USA). An alpha level
of 0.05 was considered statistically significant for all anal-
yses.
Analysis of the apoptosis assays was undertaken using
both parametric and non-parametric analysis methods.
Parametric analysis was undertaken using the student's t-
test; non-parametic analysis used the Mann-Whitney U-
test. A p-value of > 0.05 was the threshold for rejecting the
null hypothesis.
Discriminant function analysis
DFA is a method that identifies a subset of genes whose
expression values can be linearly combined in an equa-
tion, denoted a root, whose overall value is distinct for a
given characterized group. DFA therefore, allows the
genes that maximally discriminate among the distinct
groups analyzed to be identified. In the present work, aJournal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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variant of the classical DFA, named the Forward Stepwise
Analysis, was used to select the set of genes whose expres-
sion maximally discriminated among experimentally dis-
tinct groups. The Forward Stepwise Analysis was built
systematically in an iterative manner. Specifically, at each
step all variables were reviewed to identify the one that
most contributes to the discrimination between groups.
This variable was included in the model, and the process
proceeded to the next iteration. The statistical significance
of discriminative power of each gene was also character-
ized by partial Wilk's Lambda coefficients, which are
equivalent to the partial correlation coefficient generated
by multiple regression analyses. The Wilk's Lambda coef-
ficient used a ratio of within-group differences and the
sum of within-plus between-group differences. Its value
ranged from 1.0 (no discriminatory power) to 0.0 (perfect
discriminatory power).
Computer analysis of functional associations between differentially 
expressed genes
In addition to the above analyses, genes showing the most
significant differences between neonatal and adult cells
were characterized functionally using pre-existing data-
bases such as PubMed, BIND, KEGG, and Ontoexpress.
Biological associations of the differentially expressed
genes were modelled using Ingenuity Pathways Analysis
(Redwood City, CA). Data analyzed through this tech-
nique can then be resolved into cogent models of the spe-
cific biological pathways activated under the experimental
conditions used in the microarray analyses.
Results
Differential gene expression analysis
Table 1 lists genes determined to be differentially
expressed between cord and adult peripheral blood
monocytes, as described above. No genes were found to
be statistically significantly differentially expressed
between adult and cord monocytes in the absence of LPS
exposure. 168 genes were differentially expressed between
adult and cord monocytes after 45 min incubation with
LPS. 95% of these genes (159 of 168) were over-expressed
in adult relative to cord monocytes. After 120 minutes of
LPS exposure, 24 genes were differentially expressed
between adult and cord monocytes. Of the latter genes, 23
were more highly expressed in cord than adult monocytes.
This pattern of differentially expressed genes suggested an
initial delayed response to LPS followed by an enhanced
transcription of genes in cord relative to adult monocytes.
To test this hypothesis, k-means clustering was used to cat-
egorize differentially expressed genes based on their tem-
poral profiles. Relative decreases in gene transcription by
cord monocytes at 45 min were seen in 6 of the 9 clusters
(Figure 1). Each of these clusters contained between 15
and 46 genes. Examination of the clusters showed that dif-
ferences between groups after 45 minutes of LPS exposure
were attributable to a) genes in certain clusters that were
up-regulated in adult monocytes only, b) genes in other
clusters that were down-regulated in cord monocytes
only, or c) genes in yet other clusters that were up-regu-
lated in adult and down-regulated in cord monocytes.
These results, summarized in a heat map in Figure 2, indi-
cated a high complexity of gene expression differences
between adult monocytes and cord blood monocytes in
response to LPS.
In addition to the above genes which differed in expres-
sion between groups following LPS exposure, 516 genes
were also identified that were differentially expressed over
time within a group. A supplementary table containing
these data is available upon request. For these genes, a
similar pattern of dynamic expression was seen as was
observed in the other group. Therefore, these genes reflect
common responses to LPS in monocytes from both
sources.
A subset of genes that were differentially expressed either
between adult and cord blood monocytes were selected
for validation using the quantitative real-time polymerase
chain reaction method (QRT-PCR). These included four
genes that differed between groups after 45 min of LPS
exposure (Erbb3, Tmod, Dscr1l1, and Sp1), and six genes
that differed in expression after 2 hours of LPS exposure
(Scya4, Gro2, Cri1, Scya3, Scya3l1, and Il-1a). Nine of the
ten genes tested for QRT-PCR validation demonstrated
similar levels of relative expression in QRT-PCR experi-
ments as in the microarrays. Only CRI1 failed to corrobo-
rate the microarray data.
Hypervariable gene analysis
One hundred eighty-eight hypervariable (HV) genes were
selected from expressed genes in adult and cord blood
monocytes based on their changes across three time
points. These genes exhibited significantly higher expres-
sion variation over time than the majority of genes. Differ-
ences in variation between two experimental sample sets,
in this case adult and neonatal samples, can represent dif-
ferences in homeostatic control mechanisms between
these two sets [20]. The selected genes were hypervariable
in both sample groups. HV genes with highly correlated
expression levels in a given population are likely to share
function [20]. A correlation based clustering procedure
was carried out for these HV genes as described in the
methods section. Genes belonging to the 5 largest clusters
were used for creation of a graphical output, denoted a
correlation mosaic. A correlation mosaic allows identifi-
cation of the genes within clusters by visual inspection
and subsequent functional analysis of genes within clus-
ters (Figures 3A &3B). Figure 3A represents 110 genes of
the same cluster allocation between adult and cord blood
monocyte samples, demonstrating a very high similarityJournal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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Table 1: Differentially expressed genes between adult and cord monocytes at specific time points. T = time (min) at which the sample 
was taken. Numbers indicate corrected expression values.
Adult Adult Adult Cord Cord
Genbank # Symbol Gene Description T = 0 t = 45 t = 120 t = 0 t = 45 t = 120
Apoptosis
NM_033423 CTLA1 Similar to granzyme B (granzyme 2, cytotoxic T-
lymphocyte-associated serine esterase 1)
317 419 299 199 193 264
AB037796 PDCD6IP Programmed cell death 6 interacting protein 75 155 68 79 70 81
NM_024969 TAIP-2 TGFb-induced apoptosis protein 2 63 113 107 53 68 116




AK001313 RPLP0 Ribosomal protein, large, P0 704 1465 947 703 756 669
NM_006799 PRSS21 Protease, serine, 21 (testisin) 204 789 457 169 360 400
NM_003774 GALNT4 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 4 (GalNAc-T4)
576 651 648 528 378 578
AK057790 cDNA FLJ25061 fis, clone CBL04730 245 373 302 244 215 200
NM_004223 UBE2L6 Ubiquitin-conjugating enzyme E2L 6 128 191 146 108 99 109
NM_014710 GPRASP1 KIAA0443 gene product 122 182 106 113 119 95
NM_021090 MTMR3 Myotubularin related protein 3 109 171 137 108 87 138
AF339824 HS6ST3 Heparan sulfate 6-O-sulfotransferase 3 89 112 91 94 46 76
NM_012180 FBXO8 F-box only protein 8 40 67 42 45 33 43
U66589 RPL5 Ribosomal protein L5 34 48 37 30 26 36
NM_001870 CPA3 Carboxypeptidase A3 (mast cell) 183 495 610 146 949 756
NM_006145 DNAJB1 DnaJ (Hsp40) homolog, subfmaily B, member 1 179 277 408 168 299 745
AK025547 MRPL30 Mitochondrial ribosomal protein L30 83 118 126 81 101 211
NM_000439 PCSK1 Proprotein convertase subtilisin/kexin type 1 39 55 53 40 78 88
Cell/Organism 
Movement
NM_002067 GNA11 Guanine nucleotide binding protein (G protein), alpha 11 
(Gq class)
555 870 607 540 468 664
NM_002465 MYBPC1 Myosin binding protein C, slow type 81 140 154 88 80 161
NM_003275 TMOD Tropomodulin 276 151 481 257 344 503
AK026164 MYL6 Myosin, light polypeptide 6, alkali, smooth muscle and non-
muscle





Calcium channel, voltage-dependent, alpha 2/delta subunit 
2
670 1390 1021 641 639 946
AK025170 SFXN5 FLJ21517 fis, clone COL05829 431 537 437 405 295 374
NM_021097 SLC8A1 Solute carrier family 8 (sodium/calcium exchanger), 
member 1
396 456 458 412 276 369
Signal Transduction
NM_032144 RAB6C RAB6C 827 1658 1307 626 773 1251
NM_001982 ERBB3 V-erb-b2 erythroblastic leukemia viral oncogene homolog 
3
603 1375 671 555 584 643
AK026479 SNX14 Sorting nexin 14 682 1207 879 624 567 883
NM_018979 PRKWN
K1
Protein kinase, lysine deficient 1 451 813 782 516 480 792
NM_004811 LPXN Leupaxin 329 539 445 323 298 503
BC005365 clone IMAGE:3829438, mRNA, partial cds 257 418 275 275 275 206
NM_004723 ARHGEF
2
Rho/rac guanine nucleotide exchange factor (GEF) 2 215 300 228 197 176 186
AF130093 MAP3K4 Mitogen-activated protein kinase kinase kinase 4 237 285 275 221 171 223
AK000383 MKPX Mitogen-activated protein kinase phosphatase x 218 221 244 233 126 197
NM_022304 HRH2 Histamine receptor H2 45 121 86 42 74 79
NM_030753 WNT3 Wingless-type MMTV integration site family member 3 105 117 92 109 63 81
AB024574 GTPBP2 GTP binding protein 2 89 90 99 74 57 92
NM_002836 PTPRA Protein tyrosine phosphatase, receptor type, A 8 6 80 6 16 28
NM_003656 CAMK1 Calcium/calmodulin-dependent protein kinase I 4940 10131 4446 4785 4907 7190
Cellular Metabolism 
& Cell Division
NM_006170 NOL1 Nucleolar protein 1 (120 kD) 575 1815 1021 499 896 1093Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
Page 6 of 19
(page number not for citation purposes)
AL133115 COVA1 Cytosolic ovarian carcinoma antigen 1 1381 1294 848 1309 658 808
D86962 GRB10 Growth factor receptor-bound protein 10 619 906 200 609 512 179
NM_005628 SLC1A5 Solute carrier family 1 (neutral amino acid transporter), 
member 5
338 801 600 311 397 524
D17525 MASP1 Mannan-binding lectin serine protease 1 (C4/C2 activating 
component of Ra-reactive factor)
372 654 43 361 325 55
NM_016518 PIPOX Pipecolic acid oxidase 240 545 330 221 293 286
NM_012157 FBXL2 F-box and leucine-rich repeat protein 2 274 501 374 249 277 298
NM_018446 AD-017 Glycosyltransferase AD-017 301 369 337 288 223 327
NM_001609 ACADSB Acyl-Coenzyme A dehydrogenase, short/branched chain 354 368 325 273 211 276
NM_001647 APOD Apolipoprotein D 259 358 289 261 202 205
NM_012113 CA14 Carbonic anhydrase XIV 218 356 279 251 194 270
AB067472 DKFZP4
34L1435
KIAA1885 protein 150 213 186 166 119 163
NM_002916 RFC4 Replication factor C (activator 1) 4 (37 kD) 102 177 119 105 86 132
NM_004889 ATP5J2 ATP synthase, H+ transporting, mitochondrial F0 
complex, subunit f, isoform 2
106 147 76 102 76 62
AK057066 cDNA FLJ32504 fis, clone SMINT1000016, weakly similar 
to 2-hydroxyacylsphingosine 1b
69 121 126 64 75 84
AK021722 AGPAT5 Lysophosphatidic acid acyltransferase, epsilon 37 71 48 42 39 46
NM_003664 AP3B1 Adaptor-related protein complex 3, beta 1 subunit 34 52 29 37 24 30
AF146760 Sept10 Septin 10 22 36 23 26 16 28
NM_004910 PITPNM Phosphatidylinositol transfer protein, membrane-
associated
2611 2809 2410 2974 4590 2675
NM_018216 FLJ10782 Pantothenic acid kinase 10 9 10 9 18 15
NM_001714 BICD1 Bicaudal D homolog 1 (Drosophila) 230 562 407 197 447 691




DNA segment on chromosome X and Y (unique) 155 
expressed sequence
4857 3489 3214 5177 2241 2725
NM_006298 ZNF192 Zinc finger protein 192 552 988 761 537 578 820
NM_004991 MDS1 Myelodysplasia syndrome 1 401 691 480 390 361 420
NM_021784 HNF3B Hepatocyte nuclear factor 3, beta 320 632 367 347 361 391
AF153201 LOC585
02
C2H2 (Kruppel-type) zinc finger protein 288 532 335 244 297 324
NM_025212 IDAX Dvl-binding protein IDAX (inhibition of the Dvl and Axin 
complex)
297 490 311 303 254 241
AK022962 PBX1 Pre-B-cell leukemia transcription factor 1 237 456 326 245 261 345
NM_017617 NOTCH
1
Notch-1 homolog 309 358 353 324 208 370
NM_001451 FOXF1 Forkhead box F1 165 347 306 177 208 328
NM_007136 ZNF80 Zinc finger protein 80 (pT17) 199 269 203 205 143 177
NM_021975 RELA V-rel reticuloendotheliosis viral oncogene homolog A, 
nuclear factor of kappa light polypeptide gene
184 221 139 150 124 122
NM_031214 TARDBP TAR DNA binding protein 76 154 109 74 91 90
NM_014007 ZNF297B Zinc finger protein 297B 109 137 122 109 77 111
NM_014938 MONDO
A
Mlx interactor 74 90 92 69 53 86
NM_005822 DSCR1L
1
Down syndrome critical region gene 1-like 1 45 80 30 40 27 26
NM_004289 NFE2L3 Nuclear factor (erythroid-derived 2)-like 3 73 63 41 64 39 38
NM_054023 SCGB3A
2
Secretoglobin family 3a, member 2 37 59 45 43 34 49
NM_012107 BP75 Bromodomain containing protein 75 kDa human homolog 44 51 34 37 22 30
NM_007212 RNF2 Ring finger protein 2 48 40 30 45 18 26
D89859 ZFP161 Zinc finger protein 161 homolog (mouse) 500 596 4280 458 481 6699
NM_014335 CRI1 CREBBP/EP300 inhibitory protein 1 52 84 86 57 72 196
Immune Function
NM_014889 MP1 Metalloprotease 1 (pitrilysin family) 352 401 398 379 260 351
NM_014312 CTXL Cortical thymocyte receptor (X. laevis CTX) like 386 370 375 392 224 299
NM_002053 GBP1 Guanylate binding protein 1, interferon-inducible, 67 kD 259 369 334 245 214 251
NM_005356 LCK Lymphocyte-specific protein tyrosine kinase 186 206 187 235 124 181
NM_000564 IL5RA Interleukin 5 receptor, alpha 112 106 124 121 63 150
NM_001311 CRIP1 Cysteine-rich protein 1 (intestinal) 45 31 39 49 60 43
Table 1: Differentially expressed genes between adult and cord monocytes at specific time points. T = time (min) at which the sample 
was taken. Numbers indicate corrected expression values. (Continued)Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
Page 7 of 19
(page number not for citation purposes)
NM_002984 SCYA4 Small inducible cytokine A4 MIP1B 492 2001 2483 517 1523 3897
NM_002983 SCYA3 Small inducible cytokine A3 MIP1A 248 1798 2207 185 1364 3673
NM_014443 IL17B Interleukin 17B 663 696 681 706 703 1155
NM_006018 HM74 Putative chemokine receptor-GTP-binding protein 13 25 19 15 26 34
Miscellaneous 
Functions
AB033041 VANGL2 Vang, van gogh-like 2 (Drosophila) 983 1246 1351 981 796 1304
AK021444 POSTN Periostin, osteoblast specific factor 569 917 789 522 479 629
NM_003691 STK16 Serine/threonine kinase 16 403 777 458 395 348 393
NM_006438 COLEC1
0
Collectin sub-family member 10 (C-type lectin) 284 762 500 260 351 528
AK057699 FLJ33137 fis, clone UTERU1000077 375 637 613 369 392 616
NM_017671 C20orf42 Chromosome 20 open reading frame 42 362 557 551 280 323 478
AK054683 DCLRE1
C
DNA cross-link repair 1C 486 555 574 476 293 515
NM_033060 KAP4.10 Keratin associated protein 4.10 210 245 197 154 123 172
AF319045 CNTNA
P2
Contactin associated protein-like 2 112 215 173 120 113 176
NM_001046 SLC12A2 Solute carrier family 12 (sodium/potassium/chloride 
transporters), member 2
158 148 184 146 86 161
NM_016279 CDH9 Cadherin 9, type 2 (T1-cadherin) 77 112 69 65 51 64
NM_014208 DSPP Dentin sialophosphoprotein 60 90 64 57 53 59
NM_015669 PCDHB5 Protocadherin beta 5 92 83 62 98 42 47
AK023198 OPRK1 Opioid receptor, kappa 1 58 76 41 48 46 38
NM_018240 KIRREL Kin of IRRE like (Drosophila) 60 75 47 66 43 46
AK056781 ROCK1 Rho-associated, coiled-coil containing protein kinase 1 54 62 42 47 41 42
NM_022123 NPAS3 Basic-helix-loop-helix-PAS protein 17 22 91 6 12 13
NM_001246 ENTPD2 Ectonucleoside triphosphate diphosphohydrolase 2 3438 3272 3731 3767 3590 6309
Unknown Function
AK056884 FLJ32322 fis, clone PROST2003577 2007 2878 2008 1825 1548 1958
NM_017812 FLJ20420 Coiled-coil-helix-coiled-coil-helix domain containing 3 1105 1915 1370 1125 940 1358
AJ420459 LOC511
84
Protein x 0004 661 1579 881 603 771 768
BC011575 Similar to RIKEN cDNA 0610031J06 gene, clone 
IMAGE:4639306
974 1556 1412 1020 844 1261
AK057357 FLJ32926 DKFZp434D2472 1188 1378 1159 1043 515 1136
NM_025019 TUBA4 tubulin, alpha 4 1446 1173 1330 1477 782 1366
AK023150 FLJ13088 fis, clone NT2RP3002102 798 1087 905 845 564 785
NM_017833 C21orf55 Chromosome 21 open reading frame 55 741 1079 799 687 508 665
BC001407 Similar to cytochrome c-like antigen 524 1004 629 506 502 577
AK023104 FLJ22648 fis, clone HSI07329 441 984 621 488 471 495
AK024617 FLJ20964 fis, clone ADSH00902 824 955 745 788 535 824
BC009536 IMAGE:3892368 553 924 775 597 498 671
AK056287 FLJ31725 fis, clone NT2RI2006716 435 862 907 405 459 893
AK021611 FLJ11549 fis, clone HEMBA1002968 535 812 675 545 392 630
BC015119 IMAGE:3951139 445 784 487 455 435 439
AK056492 FLJ31930 fis, clone NT2RP7006162 252 651 525 266 367 457
AB058711 KIAA180
8
KIAA1808 protein 208 637 357 199 339 366
BC011266 IMAGE:4156795 354 632 432 356 328 460
AK023316 FLJ13254 fis, clone OVARC1000787 416 596 357 400 290 352
NM_024696 FLJ23058 Hypothetical protein FLJ23058 456 541 346 436 313 359
AF253316 Pheromone receptor (PHRET) pseudogene 136 520 425 128 301 347
AK056007 BICD1 Bicaudal D homolog 1 (Drosophila) 704 505 439 624 243 305
AB020632 KIAA082
5
KIAA0825 protein 249 498 353 246 272 339
NM_017609 DKFZp4
34A1721
Hypothetical protein DKFZp434A1721 182 485 319 190 298 304
NM_018190 FLJ10715 Hypothetical protein FLJ10715 202 483 310 174 206 266
AK057046 FLJ32484 fis, clone SKNMC2001555 229 473 294 261 302 228
NM_013395 AD013 Proteinx0008 448 461 496 403 304 378
BC008501 MGC148
39
Similar to RIKEN cDNA 2310030G06 379 414 329 443 264 290
Table 1: Differentially expressed genes between adult and cord monocytes at specific time points. T = time (min) at which the sample 
was taken. Numbers indicate corrected expression values. (Continued)Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
Page 8 of 19
(page number not for citation purposes)
AK021988 FLJ11926 fis, clone HEMBB1000374 321 411 399 280 218 288
AF119872 PRO2272 257 405 327 257 205 250
NM_022744 FLJ13868 Hypothetical protein FLJ13868 267 376 239 270 212 172
AK022364 FLJ12302 fis, clone MAMMA1001864 172 355 316 164 184 332
BC002644 MGC485
9
Hypothetical protein MGC4859 similar to HSPA8 282 335 382 257 223 331
AK022201 FLJ12139 fis, clone MAMMA1000339 267 302 152 235 123 131
NM_017953 FLJ20729 Hypothetical protein FLJ20729 170 290 258 138 170 218
AK057473 FLJ32911 fis, clone TESTI2006210 160 268 265 163 123 247
U50383 RAI15 Retinoic acid induced 15 206 265 236 198 159 186
AK027027 FLJ23374 fis, clone HEP16126 134 261 170 134 152 141
AK057288 FLJ32726 fis, clone TESTI2000981 206 249 312 216 152 244
U79280 PIPPIN Ortholog of rat pippin 274 229 189 238 117 134
AK023628 FLJ13566 fis, clone PLACE1008330 140 195 230 133 128 193
NM_025263 CAT56 CAT56 protein 126 194 147 127 101 130
AF311324 Ubiquitin-like fusion protein 191 189 179 190 106 138
NM_005708 GPC6 Glypican 6 107 185 144 109 88 146
AB037778 KIAA135
7
KIAA1357 protein 153 180 156 149 118 146
AK055939 FLJ31377 fis, clone NESOP1000087 152 167 179 136 105 173
NM_018316 FLJ11078 Hypothetical protein FLJ11078 89 145 118 73 94 103
AF402776 BIC BIC noncoding mRNA 82 136 171 96 88 153
BC003416 IMAGE:3450973 64 133 93 83 73 111
AL137491 DKFZp434P1530 62 130 88 57 72 74
AK057770 FLJ25041 fis, clone CBL03194 110 130 114 108 83 84
AB058769 KIAA186
6
KIAA1866 protein 89 126 122 102 83 91
AB058747 WAC WW domain-containing adapter with a coiled-coil region 60 124 103 57 76 77
AK054885 C6orf31 Chromosome 6 open reading frame 31 51 119 108 41 68 119
AK022235 FLJ12173 fis, clone MAMMA1000696 109 103 94 90 62 77
AK026853 AOAH Acyloxyacyl hydrolase (neutrophil) 59 98 64 59 61 56
AK024877 FLJ21224 fis, clone COL00694 53 96 110 55 54 103
NM_003171 SUPV3L1 Suppressor of var1, 3-like 1 (S. cerevisiae) 65 93 60 60 55 58
NM_052933 TSGA13 Testis specific, 13 66 80 70 68 44 71
AK057907 FLJ25178 fis, clone CBR09176 42 77 31 47 43 41
AK055748 FLJ31186 fis, clone KIDNE2000335 88 67 68 79 44 71
BC013757 IMAGE:4525041 40 54 39 43 33 32
AL365511 Novel human gene mapping to chomosome 22 19 48 29 20 27 37
AK026889 APRIN Androgen-induced proliferation inhibitor 31 35 42 34 21 34
AK057423 FLJ32861 fis, clone TESTI2003589 36 32 34 30 18 31
AK055543 MLSTD1 Male sterility domain containing 1 31 31 32 27 18 30
AK056513 FLJ31951 fis, clone NT2RP7007177 33 29 20 22 13 20
NM_013319 TERE1 Transitional epithelia response protein 22 28 19 24 17 22
AK026456 FLJ22803 fis, clone KAIA2685 15 26 14 16 13 17
AK021610 cDNA FLJ11548 fis, clone HEMBA1002944 34 26 29 31 15 28
AK026823 FLJ23170 fis, clone LNG09984 15 22 14 19 8 18
AK056805 FLJ32243 fis, clone PROST1000039 400 177 186 343 314 160
NM_012238 SIRT1 Sirtuin silent mating type information regulation 2 
homolog 1 (S. cerevisiae)
149 156 170 178 134 109
NM_016099 GOLGA7 golgi autoantigen, golgin subfamily a, 7 10493 15165 9882 1194
7
11564 15698
AK022482 FLJ12420 fis, clone MAMMA1003049 6052 9099 5803 6362 7620 9309
AK026490 RAB32 RAB32, member RAS oncogene family 3677 7044 4641 3671 5553 7561
NM_020684 NPD007 NPD007 protein 674 794 764 630 720 1215
AL390158 ATXN7L
3
Ataxin 7-like 3 319 460 378 339 403 598
NM_017752 FLJ20298 Hypothetical protein FLJ20298 146 237 282 133 233 493
AB037743 KIAA132
2
KIAA1322 protein 236 202 199 239 246 319
AF339819 clone IMAGE:38177 77 111 110 96 125 174
AK055215 FLJ30653 fis, clone DFNES2000143 47 48 58 43 80 92
Table 1: Differentially expressed genes between adult and cord monocytes at specific time points. T = time (min) at which the sample 
was taken. Numbers indicate corrected expression values. (Continued)Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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between cells from these two groups, as measured by the
correlation coefficients between genes from adult and
cord monocytes with value > 0.90 (figure 3A, black and
white graph to the right). Three genes on this list (#101–
103) were the exception: transcriptional regulator inter-
acting with the PHS-bromodomain 2 (Trip-Br2), inter-
leukin 1 beta (Il1b), and the GRO2 oncogene(Gro2).
These genes may play a critical role in differentiation
between adult and cord monocyte behaviour [22,23]. The
high similarity of these mosaics presents evidence for the
presence of fundamental processes in monocyte develop-
ment that appear to be quite similar in both groups of
samples. The details of the genes used in Figure 3A are pre-
sented as Table 2. Another group of 78 genes were found
that have different cluster designations between adult and
cord blood monocytes (Figure 3B). Details of these genes
are listed in Table 3.
We analyzed these genes using DFA in order to find those
genes most likely to highlight the differences between
cord and adult monocytes. DFA identified genes having
high discriminatory capabilities. The DFA software
selected genes from Table 3 with highest discriminatory
capabilities for this case. A total of 12 genes (marked with
asterisk in Table 3) were used by the DFA program to dif-
ferentiate dynamical changes in both cord and adult
monocytes after LPS stimulation. Values of the roots
obtained by DFA analysis were used to graphically depict
the differences of the gene expression values obtained in
cord and adult samples in different stages after stimula-
tion (Fig. 4). The spatial organization of the elements in
this representation provides a measure of the overall sim-
ilarity of the dynamic behaviour of these samples. The
greatest temporal changes in gene expression for cord and
adult monocytes noted above after 45 min of LPS expo-
LPS-stimulated genes in cord blood and adult monocytes can be differentiated on the basis of kinetics of expression Figure 1
LPS-stimulated genes in cord blood and adult monocytes can be differentiated on the basis of kinetics of expression. Expression 
level (in relative intensity units) is shown of the y-axis and time on the x-axis. At the 45 min time point, significant differences in 
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Heat map representation of differences in gene expression of adult and cord blood monocytes in response to LPS Figure 2
Heat map representation of differences in gene expression of adult and cord blood monocytes in response to LPS. Z-trans-
formed scores of the mean expression values for adult monocytes prior to (A0), after 45 min (A45), and after 120 min (A120) 
of LPS exposure are graphically shown to the left. Similar scores from cord blood monocytes prior to (C0), after 45 min (C45), 
and after 120 min C120) of LPS exposure, respectively. The heat map was produced using software from Spotfire Decision Site 
(Somerville, MA).Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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sure were also observed in the analysis using these 12
genes. However, almost no differences occurred at the 2 hr
time point between cord and adult cells suggesting that
the global behavior of the cells is similar, but the kinetics
of change differ i.e. many of the changes are the same in
both groups, but they occur at different rates.
Apoptosis assays
The products of a subset of genes that were differentially
expressed between groups after 45 min exposure to LPS
are involved in apoptosis. We therefore performed a series
of functional experiments comparing apoptosis in adult
(n = 10) and neonatal (n = 10) cord bloods. Results of
these assays are shown in Table 4. Annexin assays demon-
strated that adult monocytes display different kinetics for
both apoptosis and necrosis as compared with neonatal
monocytes. Flow cytometry revealed that 43 ± 5% (mean
+ SD) of adult and 53 + 8% of neonatal monocytes are
undergoing apoptosis after stimulation with LPS for 14
hours (p < 0.002), while 38 + 8% of adult and 25 + 9% of
neonatal monocytes are necrotic after 14 hours of LPS
stimulation (p < 0.003). The number of live monocytes
after 14 hours of LPS stimulation was not statistically dif-
ferent between the two groups. There was also no statisti-
cally significant difference in the number of live,
apoptotic, or necrotic monocytes between adult and neo-
natal samples prior to LPS stimulation (data not shown).
Discussion
Following a given physiologic stimulus, signalling kinase
activation, transcription factor translocation, and gene
transcription all occur in rapid order. However, like all
Correlative mosaic for genes selected as HV-genes in cord blood and adult monocytes, belonging to five clusters of highest  content Figure 3
Correlative mosaic for genes selected as HV-genes in cord blood and adult monocytes, belonging to five clusters of highest 
content. A. Genes of the same cluster in cord and adult; B. Genes of different cluster in cord and adult. Correlation coefficients 
are color-coded according to the key in the upper right. The correlation between the adult and cord blood monocyte profiles 
for each gene are shown in black and white, lower right.
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Table 2: Genes from which correlation mosaics in Figure 3A were derived. Genes in this table show the highest level of correlation by 
DFA analysis comparing adult and cord blood monocytes.
Order in mosaic Accession No. Gene symbol Description
1 NM_017614 BHMT2 Betaine-homocysteine methyltransferase 2
2 NM_001651 AQP5 Aquaporin 5
3 NM_020163 LOC56920 Semaphorin sem2
4 NM_012343 NNT Nicotinamide nucleotide transhydrogenase
5 NM_000096 CP Ceruloplasmin (ferroxidase)
6 NM_005819 STX6 Syntaxin 6
7 NM_052951 C20orf167 Chromosome 20 open reading frame 167
8 NM_001348 DAPK3 Death-associated protein kinase 3
9 X73502 KRT20 Cytokeratin 20
10 NM_052887 TIRAP Toll-interleukin 1 receptor (TIR) domain-containing adapter protein
11 NM_019555 ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3
12 NM_014380 NGFRAP1 Nerve growth factor receptor (TNFRSF16) associated protein 1
13 NM_001272 CHD3 Chromodomain helicase DNA binding protein 3
14 NM_005842 SPRY2 Sprouty homolog 2 (Drosophila)
15 NM_012332 MT-ACT48 Mitochondrial Acyl-CoA Thioesterase
16 BC015041 VATI Vesicle amine transport protein 1
17 NM_003872 NRP2 Neuropilin 2
18 NM_005849 IGSF6 Immunoglobulin superfamily, member 6
19 NM_014323 ZNF278 Zinc finger protein 278
20 NM_030674 SLC38A1 Solute carrier family 38, member 1
21 NM_004153 ORC1L Origin recognition complex, subunit 1-like (yeast)
22 NM_005249 FOXG1B Forkhead box G1B
23 NM_021048 MAGEA10 Melanoma antigen, family A, 10
24 M60502 FLG Filaggrin
25 NM_004997 MYBPH Myosin binding protein H
26 J05046 INSRR Insulin receptor-related receptor
27 M33987 CA1 Carbonic anhydrase I
28 D31886 RAB3GAP RAB3 GTPase-ACTIVATING PROTEIN
29 L24498 GADD45A Growth arrest and DNA-damage-inducible, alpha
30 L07590 PPP2R3 Protein phosphatase 2 (formerly 2A), regulatory subunit B" (PR 72), alpha isoform and (PR 130), bet
31 D87024 IGLV4-3 Immunoglobulin lambda variable 4-3
32 L35848 MS4A3 Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)
33 M18216 CEACAM6 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
34 M11952 TRBV7–8 T cell receptor beta variable 7–8
35 D89094 PDE5A Phosphodiesterase 5A, cGMP-specific
36 M77140 GAL Galanin
37 D13628 ANGPT1 Angiopoietin 1
38 M81635 EPB72 Erythrocyte membrane protein band 7.2 (stomatin)
39 D89859 ZFP161 Zinc finger protein 161 homolog (mouse)
40 D26069 CENTB2 Centaurin, beta 2
41 L10717 ITK IL2-inducible T-cell kinase
42 L04282 ZNF148 Zinc finger protein 148 (pHZ-52)
43 L41944 IFNAR2 Interferon (alpha, beta and omega) receptor 2
44 M82882 ELF1 E74-like factor 1 (ets domain transcription factor)
45 L26339 RCD-8 Autoantigen
46 D87328 HLCS Holocarboxylase synthetase (biotin-[proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase)
47 D00943 MYH6 Myosin, heavy polypeptide 6, cardiac muscle, alpha (cardiomyopathy, hypertrophic 1)
48 D00099 ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide
49 L36531 ITGA8 Integrin, alpha 8
50 D42084 METAP1 Methionyl aminopeptidase 1
51 M76766 GTF2B General transcription factor IIB
52 J04621 SDC2 Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan)
53 D31888 RCOR REST corepressor
54 L32832 ATBF1 AT-binding transcription factor 1Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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55 D86981 APPBP2 Amyloid beta precursor protein (cytoplasmic tail) binding protein 2
56 M94362 LMNB2 Lamin B2
57 M54968 KRAS2 V-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog
58 D42046 DNA2L DNA2 DNA replication helicase 2-like (yeast)
59 D86964 DOCK2 Dedicator of cyto-kinesis 2
60 D50683 TGFBR2 Transforming growth factor, beta receptor II (70–80 kD)
61 M96843 ID2B Striated muscle contraction regulatory protein




64 M63623 OMG Oligodendrocyte myelin glycoprotein
65 J04162 FCGR3B Fc fragment of IgG, low affinity IIIb, receptor for (CD16)
66 L48516 PON3 Paraoxonase 3
67 M54927 PLP1 Proteolipid protein1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated)
68 D86973 GCN1L1 GCN1 general control of amino-acid synthesis 1-like 1 (yeast)
69 D43968 RUNX1 Runt-related transcription factor 1 (acute myeloid leukemia 1-aml1 oncogene)
70 L05500 ADCY1 Adenylate cyclase 1 (brain)
71 D80010 LPIN1 Lipin 1
72 D50918 SEPT6 Septin 6
73 D86988 RENT1 Regulator of nonsense transcripts 1
74 M90391 IL16 Interleukin 16 (lymphocyte chemoattractant factor)
75 M62324 MRF-1 Modulator recognition factor I
76 L77565 DGS-H DiGeorge syndrome gene H
77 D86970 TIAF1 TGFB1-induced anti-apoptotic factor 1
78 D38169 ITPKC Inositol 1,4,5-trisphosphate 3-kinase C
79 D87684 UBXD2 UBX domain-containing 2
80 D84454 SLC35A2 Solute carrier family 35 (UDP-galactose transporter), member 2
81 M97496 GUCA2A Guanylate cyclase activator 2A (guanylin)
82 M95585 HLF Hepatic leukemia factor
83 L38517 IHH Indian hedgehog homolog (Drosophila)
84 L20860 GP1BB Glycoprotein Ib (platelet), beta polypeptide
85 M26880 UBC Ubiquitin C
86 D86962 GRB10 Growth factor receptor-bound protein 10
87 D63481 SCRIB Scribble
88 D17525 MASP1 Mannan-binding lectin serine protease 1 (C4/C2 activating component of Ra-reactive factor)
89 L26584 RASGRF1 Ras protein-specific guanine nucleotide-releasing factor 1
90 M65066 PRKAR1B Protein kinase, cAMP-dependent, regulatory, type I, beta
91 J05158 CPN2 Carboxypeptidase N, polypeptide 2, 83 kD
92 L36861 GUCA1A Guanylate cyclase activator 1A (retina)
93 L11239 GBX1 Gastrulation brain homeo box 1
94 D90145 SCYA3L1 Small inducible cytokine A3-like 1
95 M96739 NHLH1 Nescient helix loop helix 1
96 M12959 TRA@ T cell receptor alpha locus
97 D80005 C9orf10 C9orf10 protein
98 M13231 TRGC2 T cell receptor gamma constant 2
99 D28588 SP2 Sp2 transcription factor
100 M57732 TCF1 Transcription factor 1, hepatic-LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor
101 NM_014755 TRIP-Br2 Transcriptional regulator interacting with the PHS-bromodomain 2
102 NM_000576 IL1B Interleukin 1, beta
103 NM_002089 GRO2 GRO2 oncogene
104 NM_002089x GPRC5D G protein-coupled receptor, family C, group 5, member D
105 NM_002713 PPP1R8 Protein phosphatase 1, regulatory (inhibitor) subunit 8
106 NM_014383 TZFP Testis zinc finger protein
107 NM_012248 SPS2 Selenophosphate synthetase 2
108 AL137438 SEC15L SEC15 (S. cerevisiae)-like
109 NM_005387 NUP98 Nucleoporin 98 kD
110 NM_003476 CSRP3 Cysteine and glycine-rich protein 3 (cardiac LIM protein)
Table 2: Genes from which correlation mosaics in Figure 3A were derived. Genes in this table show the highest level of correlation by 
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Table 3: Genes from which the mosaic in Figure 3B were derived. Genes from which correlation mosaics in Figure 3B were derived. 
Genes in this table show the greatest differences by DFA analysis comparing adult and cord blood monocytes.
Order in Mosaic Accession No. Gene Symbol Description
1 AK055855 CLDN10 Claudin 10
2 NM_000565 IL6R Interleukin 6 receptor
3 NM_006150 LMO6 LIM domain only 6
4 NM_022787 NMNAT NMN adenylyltransferase-nicotinamide mononucleotide adenylyl transferase
5 NM_002743 PRKCSH Protein kinase C substrate 80K-H
6 NM_004847 AIF1 Allograft inflammatory factor 1
7 NM_021073 BMP5 Bone morphogenetic protein 5
* 8 AK025306 CLK1 CDC-like kinase 1
9 NM_004280 EEF1E1 Eukaryotic translation elongation factor 1 epsilon 1
* 10 NM_004432 ELAVL2 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B)
11 NM_012181 FKBP8 FK506 binding protein 8 (38 kD)
12 NM_002091 GRP Gastrin-releasing peptide
13 NM_016355 LOC51202 Hqp0256 protein
14 NM_021204 MASA E-1 enzyme
15 NM_004204 PIGQ Phosphatidylinositol glycan, class Q
16 NM_002928 RGS16 Regulator of G-protein signalling 16
17 NM_005839 SRRM1 Serine/arginine repetitive matrix 1
18 NM_003166 SULT1A3 Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
19 NM_000356 TCOF1 Treacher Collins-Franceschetti syndrome 1
20 NM_016437 TUBG2 Tubulin, gamma 2
* 21 NM_022568 ALDH8A1 Aldehyde dehyrdogenase 8 family, member A1
22 AF209930 CHRD Chordin
23 NM_005274 GNG5 Guanine nucleotide binding protein (G protein), gamma 5
24 NM_018384 IAN4L1 Immune associated nucleotide 4 like 1 (mouse)
25 NM_000640 IL13RA2 Interleukin 13 receptor, alpha 2
26 AK021692 LOC51141 Insulin induced protein 2
27 NM_012443 SPAG6 Sperm associated antigen 6
28 NM_003155 STC1 Stanniocalcin 1
29 NM_022003 FXYD6 FXYD domain-containing ion transport regulator 6
30 NM_002763 PROX1 Prospero-related homeobox 1
31 NM_002836 PTPRA Protein tyrosine phosphatase, receptor type, A
32 AL136835 TOLLIP Toll-interacting protein
33 AB058691 ALX4 Aristaless-like homeobox 4
34 AF112345 ITGA10 Integrin, alpha 10
35 NM_022788 P2RY12 Purinergic receptor P2Y, G protein-coupled, 12
36 NM_001213 C1orf1 Chromosome 1 open reading frame 1
37 NM_005860 FSTL3 Follistatin-like 3 (secreted glycoprotein)Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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38 NM_013320 HCF-2 Host cell factor 2
39 NM_058246 LOC136442 Similar to MRJ gene for a member of the DNAJ protein family
40 NM_020169 LXN Latexin protein
41 BC008993 MGC17337 Similar to RIKEN cDNA 5730528L13 gene
42 BC002712 MYCN V-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)
43 AK026164 MYL6 Myosin, light polypeptide 6, alkali, smooth muscle and non-muscle
44 NM_006215 SERPINA4 Serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
45 NM_004790 SLC22A6 Solute carrier family 22 (organic anion transporter), member 6
46 NM_022911 SLC26A6 Solute carrier family 26, member 6
47 NM_003374 VDAC1 Voltage-dependent anion channel 1
48 NM_017818 WDR8 WD repeat domain 8
49 NM_003416 ZNF7 Zinc finger protein 7 (KOX 4, clone HF.16)
50 NM_002313 ABLIM Actin binding LIM protein
51 NM_012074 CERD4 Cer-d4 (mouse) homolog
52 NM_000787 DBH Dopamine beta-hydroxylase (dopamine beta-monooxygenase)
* 53 NM_000561 GSTM1 Glutathione S-transferase M1
54 BC014075 GTPBP1 GTP binding protein 1
55 NM_033260 HFH1 Winged helix/forkhead transcription factor
56 NM_033033 KRTHB2 Keratin, hair, basic, 2
57 NM_004789 LHX2 LIM homeobox protein 2
58 NM_014106 PRO1914 PRO1914 protein
* 59 NM_006799 PRSS21 Protease, serine, 21 (testisin)
* 60 NM_002900 RBP3 Retinol binding protein 3, interstitial
61 NM_033022 RPS24 Ribosomal protein S24
* 62 AB029021 TRIM35 Tripartite motif-containing 35
* 63 NM_020989 CRYGC Crystallin, gamma C
* 64 BI198124 HMG1L10 High-mobility group (nonhistone chromosomal) protein 1-like 10
65 NM_014163 HSPC073 HSPC073 protein
66 AF181985 JIK STE20-like kinase
67 NM_017607 PPP1R12C Protein phosphatase 1, regulatory (inhibitor) subunit 12C
* 68 NM_002873 RAD17 RAD17 homolog (S. pombe)
69 NM_022095 ZNF335 Zinc finger protein 335
* 70 M90355 BTF3L2 Basic transcription factor 3, like 2
71 NM_002079 GOT1 Glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)
72 NM_004146 NDUFB7 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18 kD, B18)
73 L38486 MFAP4 Microfibrillar-associated protein 4
* 74 AF111848 ACTB Actin, beta
75 NM_001916 CYC1 Cytochrome c-1
Table 3: Genes from which the mosaic in Figure 3B were derived. Genes from which correlation mosaics in Figure 3B were derived. 
Genes in this table show the greatest differences by DFA analysis comparing adult and cord blood monocytes. (Continued)Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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biological processes, mRNA accumulation (or decreases)
does not occur uniformly, and we hypothesized that
examining the kinetics of mRNA accumulation or disap-
pearance might provide clues into relevant cellular
dynamics. We used a well-developed and validated gene
expression microarray to examine the dynamics of mRNA
accumulation and differences between adult and neonatal
monocytes in that process.
Genes were found to be differentially expressed between
adult and cord monocytes after either 45 or 120 minutes
of LPS exposure, with little difference at 24 hr (see Figure
4). Interestingly, no statistically significant differences in
gene expression were observed between these groups in
untreated cells. Previous reports by others indicated
altered functions of cord blood monocytes in cytokine
secretion and cellular adhesion. Results from this study
cast new light on these findings and add complexity to
understanding such differences. In some cases, our data
support previous speculations about neonatal immune
function. For example, the increased expression of IL-17B
in neonatal monocytes is consistent with the observations
of Vanden Eijnden and colleagues that newborns com-
pensate for their relative immune deficiency by over-
expression of the IL23-IL-17 signalling pathway in den-
dritic cells [24]. Similarly, we found significant elevations
in cord monocyte transcripts of the chemokines MIP1B
and MIP1A after 2 hrs of LPS exposure, consistent with
Sullivan and colleagues' report of higher amounts of
MIPα in cord blood samples compared with adults [25].
DFA analysis of phases of monocyte activation comparing cord and adult cells Figure 4
DFA analysis of phases of monocyte activation comparing cord and adult cells. DFA identified a subset of genes (see Table 3) 
whose expression values can be linearly combined in an equation, denoted a root, whose overall value is distinct for a given 
characterized group. These roots used as coordinate for presentation of these groups of samples in scatterplot. Results from 
individual samples for adult monocyte (circles) and cord monocytes (triangles) are discussed in the text. Results from individual 
samples for adult monocyte (circles) and cord monocytes (triangles) are shown.











24hrJournal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
Page 17 of 19
(page number not for citation purposes)
On the other hand, transcripts for cadherin 9, Rock1, peri-
ostin, heparin sulfate 6-O-sulfotransferase 3, and
C20orf42, whose products participate in various mecha-
nisms that are associated with adhesion [26-28] were sta-
tistically significantly increased in adult monocytes after
45 min of LPS exposure, although no differences in
expression for these genes between groups were detected
at the later time point. These data suggest complex,
dynamic relations for genes whose products are associated
with cellular adhesion, and collectively highlight the
importance of examining gene expression profiles (or
related protein expression levels) over time.
The limits of gene expression profiling as a technique,
albeit a very useful technique, must be acknowledged. The
technique examines only RNA transcripts, not protein
synthesis. Thus, alterations in other critical inflammatory
mediators, such as eicosanoids, remain unobserved with
this method. Furthermore, it is well known that there are
many proteins, including critical inflammatory media-
tors, whose synthesis and secretion is not directly related
in mRNA accumulation [29]. Thus, gene expression pro-
filing should be complemented with other methods in
order to maximize there potential.
In the final analysis, the utility of gene expression profil-
ing will be demonstrated only if they provide insights into
relevant physiologic or pathophysiologic function. For
that reason, we elected to test the validity of the array data
by examining a physiologic mechanism implicated by
computer modelling of the array data. As noted in Table
1, adult monocytes over-expressed a small number of
genes associated with the regulation of apoptosis. Since
monocyte activation is a "balancing act" between signals
inducing apoptosis and those inducing activation and dif-
ferentiation [30,31], differences in the kinetics of expres-
sion or activation of enzymes or transcription factors that
regulate apoptosis could have a crucial outcome on
whether monocyte responses are pro- or anti-inflamma-
tory. Annexin assays confirmed that there are significant
differences in the appearance of apoptotic cells between
adults and newborn monocytes (Table 4). Since apoptotic
cells dampen the inflammatory response, it is interesting
to speculate that the related blunted neonatal response to
inflammatory stimuli (including infection) may result, at
least in part, from the excessive production of apoptotic
cells during monocyte activation.
There has been, to our knowledge, one previously pub-
lished paper using gene expression arrays to study neona-
tal monocyte function [14]. Our findings differ somewhat
from those described by these authors. The most obvious
difference was our finding of no statistically significant
differences between adult and cord blood samples in the
resting state. We should note, however, that it is otherwise
difficult to compare the two studies. Jiang and colleagues
used a 1000-fold greater dose of LPS to stimulate the
monocytes, and RNA was prepared after 18 hr of stimula-
tion. Thus, it is difficult to determine which of the effects
observed by these authors were the direct result of LPS
activation or were mediated through autocrine activation
by proteins secreted in response to LPS. Furthermore, the
non-physiologic dose of LPS used by those authors makes
the biological/pathological relevance of that study diffi-
cult to interpret. Finally, we should note that the study by
Jiang and colleagues used different methodologies for
purifying monocytes. While our method, positive selec-
tion using CD14-coated microbeads, carries the theoreti-
cal risk of activating the cells through TLR-4/CD14
signaling pathways, adherence procedures carry the
greater risk of activating the cells, as β2 integrins are acti-
vated during the adherence process.
From the bioinformatics standpoint, our data demon-
strate how gene microarray experiments can quickly move
from the generation of gene lists to the development of
plausible and testable models of relevant biology and
physiology. Specifically, they demonstrate that computer-
assisted, physiologic modelling is another means of cor-
roborating array findings and provides the advantage of
providing an approach for immediately testing the biolog-
ical relevance of microarray data before embarking on the
sometimes laborious task of confirming differential
expression of dozens or even hundreds of genes identified
in a microarray experiment. As described in the results sec-
tion, the differences between groups in gene expression at
45 min were attributable to a unique up-regulation of spe-
cific genes in adult monocytes, a unique down-regulation
of other genes in cord monocytes, or a combination of
both processes for other genes. We have searched for
mechanisms that account for these patterns. Specifically,
we have analyzed the genes within derived k-means clus-
ters to determine if a large number of genes within a clus-
ter are related to overlapping functions using Ingenuity
Pathway Assist software, or alternatively to shared tran-
scriptional response elements upstream of these genes.
Table 4: Results of Annexin Binding Assays
Cell Type Apoptotic Cells Necrotic Cells Significance
Adult monocytes 43 ± 5% 38 % ± 8% P < 0.002
Cord blood monocytes 53 ± 8% 25% ± 9% P < 0.003Journal of Inflammation 2007, 4:4 http://www.journal-inflammation.com/content/4/1/4
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However, these strategies have failed to elucidate reasons
to explain these findings.
Our studies also suggest that, while expensive and time-
consuming to undertake, studying the kinetics of gene
expression using microarrays can be highly informative.
The previously reported study [14] examining gene
expression differences between adult and cord blood
monocytes was performed at only a single time point (18
hr after activation with a non-physiologic dose of LPS).
Our studies suggest that the relevant biology may lie not
in the specific genes that are differentially expressed at one
particular time point, but, as one would predict with a
dynamic system, which genes are expressed when. Timing
of mRNA accumulation could determine, among other
things, whether pro-apoptotic signals are processed in
monocytes before cellular necrosis ensues.
The validity of the dynamic/kinetic approach is further
supported by the correlation analyses (Figures 3 and 4).
These analyses demonstrate clearly that the accumulation
of a specific mRNA is not an independent event. Gene
transcription and mRNA degradation are dynamic proc-
esses closely tied to the accumulation or degradation of
other mRNAs and the transcription of their cognate pro-
teins. We contend that, without this dynamic view of cel-
lular activity, investigators attempting to use microarray
data to elucidate relevant biological or pathological proc-
esses will encounter unnecessary obstacles in attempts to
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